The growing phenomenon of genetic testing will give consumers a blurry crystal ball that, like the fortune-telling of fairy tales or mythology, is certain to create as much conflict as it averts.
But manufacturers of direct-to-consumer (DTC) genetic tests -- as well as the companies that make the therapeutic interventions that might be used as a result of such tests -- have an opportunity as a result.
By satisfying customer cravings for guidance about when and how to use DTC genetic tests, manufacturers have the opportunity to establish a distinctive foothold in the marketplace.
And manufacturers need to do this before it is done for them in ways they might not want.